Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001723128-26-000011
Filing Date
2026-02-27
Accepted
2026-02-27 16:19:47
Documents
150
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amrx-20251231.htm   iXBRL 10-K 3470108
2 EX-10.14 amrx-2025123110xkxprsuagre.htm EX-10.14 91806
3 EX-21.1 amrx2025311210-kexx211.htm EX-21.1 16643
4 EX-23.1 amrx-2025123110xkexx231.htm EX-23.1 5645
5 EX-31.1 amrx-2025123110xkexx311.htm EX-31.1 10564
6 EX-31.2 amrx-2025123110xkexx312.htm EX-31.2 10561
7 EX-31.3 amrx-2025123110xkexx313.htm EX-31.3 10618
8 EX-32.1 amrx-2025123110xkexx321.htm EX-32.1 5642
9 EX-32.2 amrx-2025123110xkexx322.htm EX-32.2 5569
10 EX-32.3 amrx-2025123110xkexx323.htm EX-32.3 5752
16 STOCK PERFORMANCE GRAPH amrx-20251231_g1.jpg GRAPHIC 240917
  Complete submission text file 0001723128-26-000011.txt   19885473

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20251231.xsd EX-101.SCH 140386
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20251231_cal.xml EX-101.CAL 164500
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20251231_def.xml EX-101.DEF 705976
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20251231_lab.xml EX-101.LAB 1393403
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20251231_pre.xml EX-101.PRE 1055701
153 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20251231_htm.xml XML 3423148
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38485 | Film No.: 26700249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)